Cell cycle regulation by the B-Myb transcription factor

[1]  M. Botchan,et al.  Role for a Drosophila Myb-containing protein complex in site-specific DNA replication , 2002, Nature.

[2]  M. Saville,et al.  B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107 , 2002, Oncogene.

[3]  I. Trougakos,et al.  Clusterin/apolipoprotein J in human aging and cancer. , 2002, The international journal of biochemistry & cell biology.

[4]  B. Calabretta,et al.  Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation , 2002, Cell Death and Differentiation.

[5]  G. Ramsay,et al.  Drosophila myb exerts opposing effects on S phase, promoting proliferation and suppressing endoreduplication. , 2002, Development.

[6]  J. Massagué,et al.  E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.

[7]  B. Calabretta,et al.  Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms* , 2002, The Journal of Biological Chemistry.

[8]  D. McDonnell,et al.  The Transcription Factor B-Myb Is Maintained in an Inhibited State in Target Cells through Its Interaction with the Nuclear Corepressors N-CoR and SMRT , 2002, Molecular and Cellular Biology.

[9]  J. Lipsick,et al.  Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Brian David Dynlacht,et al.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.

[11]  Arend Sidow,et al.  Inference of functional regions in proteins by quantification of evolutionary constraints , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Ishii,et al.  Myb controls G2/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc , 2002, The EMBO journal.

[13]  M. Rosenfeld,et al.  Biological roles and mechanistic actions of co-repressor complexes. , 2002, Journal of cell science.

[14]  Robert E. Lewis,et al.  Effects of B-Myb on Gene Transcription , 2002, The Journal of Biological Chemistry.

[15]  G. Ramsay,et al.  Mutations in Drosophila myb lead to centrosome amplification and genomic instability. , 2002, Development.

[16]  K. Klempnauer,et al.  Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb. , 2001, European journal of biochemistry.

[17]  B. Lüscher,et al.  The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties. , 2001, Nucleic acids research.

[18]  R. Bernards,et al.  B-myb rescues ras-induced premature senescence, which requires its transactivation domain. , 2001, Cancer letters.

[19]  N. L. La Thangue,et al.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.

[20]  M. Saville,et al.  Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator , 2001, Oncogene.

[21]  C. Readhead,et al.  Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. , 2001, Blood.

[22]  Tohru Kimura,et al.  Alteration of cell adhesion and cell cycle properties of ES cells by an inducible dominant interfering Myb mutant , 2001, Oncogene.

[23]  N. Dyson,et al.  p107 and p130: versatile proteins with interesting pockets. , 2001, Experimental cell research.

[24]  S. Ishii,et al.  Increased Affinity of c-Myb for CREB-binding Protein (CBP) after CBP-induced Acetylation* , 2001, The Journal of Biological Chemistry.

[25]  P. Farnham,et al.  Target Gene Specificity of E2F and Pocket Protein Family Members in Living Cells , 2000, Molecular and Cellular Biology.

[26]  R. Hay,et al.  Regulation of transcription factors by protein degradation , 2000, Cellular and Molecular Life Sciences CMLS.

[27]  B. Calabretta,et al.  Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB* , 2000, The Journal of Biological Chemistry.

[28]  K. Klempnauer,et al.  Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCFp45Skp2 pathway , 2000, Oncogene.

[29]  A. Sala,et al.  Poly(ADP-ribose) Polymerase Is a B-MYB Coactivator* , 2000, The Journal of Biological Chemistry.

[30]  Joseph B. Rayman,et al.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. , 2000, Genes & development.

[31]  J. Trimarchi,et al.  E2f3 is critical for normal cellular proliferation. , 2000, Genes & development.

[32]  A. Giordano,et al.  Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation , 2000, Oncogene.

[33]  S. Tsuzuki,et al.  c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300 , 2000, Oncogene.

[34]  T K Johnson,et al.  Phosphorylation of B-Myb Regulates Its Transactivation Potential and DNA Binding* , 1999, The Journal of Biological Chemistry.

[35]  H. Koeffler,et al.  c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression. , 1999, Blood.

[36]  S. Ishii,et al.  B-myb Is Required for Inner Cell Mass Formation at an Early Stage of Development* , 1999, The Journal of Biological Chemistry.

[37]  J. Whitsett,et al.  Transcriptional Regulation of the Murine Surfactant Protein-A Gene by B-Myb* , 1999, The Journal of Biological Chemistry.

[38]  G. Tonini,et al.  Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. , 1999, Cancer research.

[39]  G. Sonenshein,et al.  B-Myb represses trans-activation of the Col5A2 collagen promoter indirectly via inhibition of binding of factors interacting with positive elements within the first exon. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[40]  C. Franceschi,et al.  Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. , 1999, Cancer research.

[41]  Pasquale De Luca,et al.  B-MYB transactivates its own promoter through SP1-binding sites , 1999, Oncogene.

[42]  M. Nugent,et al.  Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  S. Elledge,et al.  The role of protein stability in the cell cycle and cancer. , 1998, Biochimica et biophysica acta.

[44]  J. Bishop,et al.  Drosophila myb is required for the G2/M transition and maintenance of diploidy. , 1998, Genes & development.

[45]  A. Leutz,et al.  B-Myb, a repressed trans-activating protein , 1997, Journal of Molecular Medicine.

[46]  M. Oelgeschläger,et al.  Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules. , 1997, The Biochemical journal.

[47]  N. Dyson,et al.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. , 1997, Genes & development.

[48]  R. Watson,et al.  B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation , 1997, Oncogene.

[49]  A. Toscani,et al.  Arrest of spermatogenesis and defective breast development in mice lacking A-myb , 1997, Nature.

[50]  K. Klempnauer,et al.  Phosphorylation and activation of B-Myb by cyclin A–Cdk2 , 1997, Current Biology.

[51]  D. Kroll,et al.  c-Myb trans-Activates the Human DNA Topoisomerase IIα Gene Promoter* , 1997, The Journal of Biological Chemistry.

[52]  H P Koeffler,et al.  Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. , 1997, Cancer research.

[53]  C. Peschle,et al.  Activation of human B-MYB by cyclins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Peschle,et al.  The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.

[55]  E. Reddy,et al.  Temporal patterns of A-myb and B-myb gene expression during testis development. , 1996, Oncogene.

[56]  R. Watson,et al.  E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. , 1996, Oncogene.

[57]  R. Watson,et al.  Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. , 1996, Oncogene.

[58]  K. Klempnauer,et al.  Expression of B-Myb during mouse embryogenesis. , 1996, Oncogene.

[59]  C. Peschle,et al.  B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells (*) , 1996, The Journal of Biological Chemistry.

[60]  F. C. Lucibello,et al.  Cell Cycle Regulation of E2F Site Occupation in Vivo , 1996, Science.

[61]  G. Sonenshein,et al.  B-Myb Expression in Vascular Smooth Muscle Cells Occurs in a Cell Cycle-dependent Fashion and Down-regulates Promoter Activity of Type I Collagen Genes (*) , 1996, The Journal of Biological Chemistry.

[62]  B. Hoffman,et al.  B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. , 1996, Oncogene.

[63]  K. Klempnauer,et al.  Differential splicing of the mouse B-myb gene. , 1995, Oncogene.

[64]  B. Dynlacht,et al.  p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. , 1995, Genes & development.

[65]  H. Stunnenberg,et al.  BS69, a novel adenovirus E1A‐associated protein that inhibits E1A transactivation. , 1995, The EMBO journal.

[66]  E. Harlow,et al.  The pRB‐related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. , 1995, The EMBO journal.

[67]  T. Nagase,et al.  c-Myb Repression of c- erbB-2 Transcription by Direct Binding to the c- erbB-2 Promoter (*) , 1995, The Journal of Biological Chemistry.

[68]  B. Calabretta,et al.  Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells (*) , 1995, The Journal of Biological Chemistry.

[69]  N. Nomura,et al.  Human A‐myb gene encodes a transcriptional activator containing the negative regulatory domains , 1995, FEBS letters.

[70]  N. Copeland,et al.  Mouse A‐myb encodes a trans‐activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. , 1994, The EMBO journal.

[71]  M. Fiscella,et al.  Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Castellano,et al.  The human A-myb protein is a strong activator of transcription. , 1994, Oncogene.

[73]  H. Moses,et al.  Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[74]  T. Crook,et al.  HPV16 E7 oncoprotein deregulates B‐myb expression: correlation with targeting of p107/E2F complexes. , 1994, The EMBO journal.

[75]  S. Ishii,et al.  Functional domains of the human B-myb gene product. , 1993, The Journal of biological chemistry.

[76]  K. Klempnauer,et al.  TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. , 1993, Oncogene.

[77]  E. Lam,et al.  Transcription regulation by murine B-myb is distinct from that by c-myb. , 1993, Nucleic acids research.

[78]  J. Lipsick,et al.  Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. , 1992, Genes & development.

[79]  B. Calabretta,et al.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[80]  E. Lam,et al.  Characterization and cell cycle-regulated expression of mouse B-myb. , 1992, Oncogene.

[81]  G. Mizuguchi,et al.  Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. , 1992, Oncogene.

[82]  A. Mantovani,et al.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. , 1992, Blood.

[83]  T. Graf.  Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells , 1992, Current Biology.

[84]  B. Calabretta,et al.  Growth regulated expression of B‐MYB in fibroblasts and hematopoietic cells , 1991, Journal of cellular physiology.

[85]  R. Watson,et al.  Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein. , 1991, Nucleic acids research.

[86]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[87]  T. Nagase,et al.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Bishop,et al.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb , 1989, Cell.

[89]  N. Nomura,et al.  Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. , 1988, Nucleic acids research.

[90]  A. E. Sippel,et al.  Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.

[91]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[92]  R. Morimoto,et al.  Expression of human HSP70 during the synthetic phase of the cell cycle. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[93]  S. Aaronson,et al.  Differential expression of the amv gene in human hematopoietic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Joseph B. Rayman,et al.  E 2 F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC 1 / mSin 3 B corepressor complex , 2002 .

[95]  Robert E. Lewis,et al.  PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites , 2001, Oncogene.

[96]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[97]  E. Lam,et al.  Cell-cycle regulation of human B-myb transcription. , 1995, Gene.

[98]  M. Arsura,et al.  Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells , 1991 .